Latest Articles
Developing a menstrual-blood-based diagnostic for endometriosis, with Yana Aznavour, MD, PhD - Contemporary OB/GYN
Developing a menstrual-blood-based diagnostic for endometriosis, with Yana Aznavour, MD, PhD Contemporary OB/GYN
Published: May 22, 2026, 5:16 p.m.
Woman with 'top 1% vagina' could be about to solve disease 190M women suffer from worldwide - UNILAD Tech
Woman with 'top 1% vagina' could be about to solve disease 190M women suffer from worldwide UNILAD Tech
Published: May 22, 2026, 10:44 a.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Published: May 22, 2026, 3:43 a.m.
Is this the first disease-modifying treatment for endometriosis? - Drug Discovery News
Is this the first disease-modifying treatment for endometriosis? Drug Discovery News
Published: May 20, 2026, 8:03 p.m.
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results - Yahoo Finance
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results Yahoo Finance
Published: May 20, 2026, 6:22 p.m.
Merck's Sac-TMT meets both endpoints in phase 3 endometrial cancer trial - MSN
Merck's Sac-TMT meets both endpoints in phase 3 endometrial cancer trial MSN
Published: May 20, 2026, 6:16 a.m.
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial - TipRanks
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial TipRanks
Published: May 19, 2026, 4:44 p.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times
Published: May 19, 2026, 3:15 p.m.
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer - Indian Pharma Post
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer Indian Pharma Post
Published: May 19, 2026, 9:08 a.m.
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz
Published: May 19, 2026, 6:54 a.m.
Link copied to clipboard!